Best TWAS P=6.77e-17 · Best GWAS P=1.7e-12 conditioned to 0.381
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | CCDC144B | 0.21 | 0.05 | enet | 30 | 0.16 | 1.5e-18 | -1.77 | -5.6 | 2.4e-08 | 0.34 | 0.24 | 0.76 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | FAM106A | 0.05 | 0.01 | bslmm | 278 | 0.02 | 8.6e-04 | -6.09 | -6.6 | 4.3e-11 | 0.59 | 0.04 | 0.59 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | LLGL1 | 0.09 | 0.02 | enet | 14 | 0.04 | 4.8e-06 | -6.69 | -5.9 | 3.3e-09 | 0.66 | 0.02 | 0.97 | FALSE |
4 | GTEx | Adipose Subcutaneous | CTD-2303H24.2 | 0.16 | 0.11 | enet | 15 | 0.18 | 2.4e-14 | 5.37 | -5.3 | 8.8e-08 | 0.17 | 0.83 | 0.17 | FALSE |
5 | GTEx | Adipose Visceral Omentum | CTD-2303H24.2 | 0.35 | 0.10 | enet | 14 | 0.23 | 2.8e-12 | -6.64 | -5.5 | 3.6e-08 | 0.11 | 0.04 | 0.96 | FALSE |
6 | GTEx | Adrenal Gland | MIEF2 | 0.34 | 0.19 | lasso | 7 | 0.26 | 8.1e-10 | -6.12 | 7.8 | 6.6e-15 | -0.73 | 0.03 | 0.97 | FALSE |
7 | GTEx | Adrenal Gland | CTD-2303H24.2 | 0.31 | 0.05 | lasso | 7 | 0.12 | 3.6e-05 | -6.43 | -8.2 | 1.6e-16 | 0.52 | 0.10 | 0.65 | FALSE |
8 | GTEx | Artery Aorta | LLGL1 | 0.34 | 0.05 | lasso | 9 | 0.12 | 4.0e-07 | -6.09 | -5.7 | 1.0e-08 | 0.59 | 0.05 | 0.92 | FALSE |
9 | GTEx | Artery Aorta | MIEF2 | 0.14 | 0.04 | lasso | 6 | 0.07 | 6.7e-05 | 2.46 | 5.8 | 5.8e-09 | -0.66 | 0.03 | 0.88 | FALSE |
10 | GTEx | Artery Aorta | CTD-2303H24.2 | 0.39 | 0.12 | enet | 37 | 0.27 | 3.7e-15 | 5.37 | -5.9 | 3.0e-09 | 0.24 | 0.07 | 0.93 | FALSE |
11 | GTEx | Breast Mammary Tissue | CCDC144B | 0.19 | 0.00 | enet | 18 | 0.06 | 4.0e-04 | 0.84 | 6.4 | 1.5e-10 | -0.29 | 0.05 | 0.13 | FALSE |
12 | GTEx | Breast Mammary Tissue (Female) | CCDC144B | 0.31 | 0.01 | lasso | 6 | 0.06 | 9.1e-03 | 2.02 | 5.7 | 1.2e-08 | -0.41 | 0.03 | 0.26 | FALSE |
13 | GTEx | Breast Mammary Tissue (Female) | TOP3A | 0.29 | 0.00 | lasso | 4 | 0.06 | 8.0e-03 | -7.06 | 5.6 | 2.5e-08 | -0.63 | 0.02 | 0.65 | FALSE |
14 | GTEx | Cells Transformed fibroblasts | ALKBH5 | 0.16 | 0.05 | lasso | 7 | 0.10 | 9.2e-08 | 3.51 | 6.2 | 6.5e-10 | -0.64 | 0.11 | 0.89 | FALSE |
15 | GTEx | Cells Transformed fibroblasts | TOP3A | 0.32 | 0.12 | enet | 31 | 0.12 | 2.3e-09 | -6.09 | 5.5 | 4.2e-08 | -0.68 | 0.13 | 0.87 | FALSE |
16 | GTEx | Cells Transformed fibroblasts | RP11-258F1.1 | 0.18 | 0.12 | lasso | 3 | 0.15 | 1.7e-11 | 3.51 | 5.6 | 2.2e-08 | -0.54 | 0.82 | 0.18 | FALSE |
17 | GTEx | Esophagus Gastroesophageal Junction | CTD-2303H24.2 | 0.33 | 0.20 | lasso | 3 | 0.34 | 6.0e-13 | 5.37 | -6.6 | 4.2e-11 | 0.23 | 0.08 | 0.92 | FALSE |
18 | GTEx | Esophagus Mucosa | CTD-2303H24.2 | 0.21 | 0.09 | enet | 29 | 0.17 | 2.4e-11 | 5.37 | -6.3 | 2.3e-10 | 0.20 | 0.16 | 0.84 | FALSE |
19 | GTEx | Esophagus Muscularis | LLGL1 | 0.19 | 0.06 | lasso | 5 | 0.06 | 1.1e-04 | -6.09 | -6.8 | 1.3e-11 | 0.42 | 0.07 | 0.92 | FALSE |
20 | GTEx | Esophagus Muscularis | CTD-2303H24.2 | 0.25 | 0.09 | lasso | 5 | 0.16 | 8.4e-10 | 5.37 | -5.6 | 2.2e-08 | 0.18 | 0.12 | 0.88 | FALSE |
21 | GTEx | Heart Left Ventricle | CTD-2303H24.2 | 0.24 | 0.04 | lasso | 6 | 0.10 | 4.3e-06 | -6.64 | -5.8 | 5.5e-09 | 0.17 | 0.08 | 0.91 | FALSE |
22 | GTEx | Liver | SHMT1 | 0.36 | 0.22 | lasso | 4 | 0.20 | 3.5e-06 | -6.10 | -5.9 | 3.4e-09 | 0.63 | 0.06 | 0.89 | FALSE |
23 | GTEx | Lung | CTD-2303H24.2 | 0.45 | 0.12 | lasso | 6 | 0.27 | 1.3e-20 | -1.77 | -5.2 | 1.6e-07 | 0.21 | 0.97 | 0.03 | FALSE |
24 | GTEx | Muscle Skeletal | MIEF2 | 0.19 | 0.12 | lasso | 1 | 0.11 | 1.6e-10 | -6.12 | 6.1 | 9.2e-10 | -0.64 | 0.18 | 0.82 | FALSE |
25 | GTEx | Muscle Skeletal | CTD-2303H24.2 | 0.23 | 0.11 | enet | 23 | 0.17 | 5.2e-16 | 5.37 | -6.1 | 1.1e-09 | 0.24 | 0.75 | 0.25 | FALSE |
26 | GTEx | Nerve Tibial | CTD-2303H24.2 | 0.23 | 0.08 | enet | 15 | 0.18 | 9.4e-13 | 5.37 | -5.6 | 2.0e-08 | 0.21 | 0.57 | 0.43 | FALSE |
27 | GTEx | Skin Sun Exposed Lower leg | CTD-2303H24.2 | 0.24 | 0.08 | enet | 20 | 0.13 | 3.9e-11 | -1.77 | -5.5 | 3.7e-08 | 0.14 | 0.91 | 0.09 | FALSE |
28 | GTEx | Small Intestine Terminal Ileum | CTD-2303H24.2 | 0.38 | 0.28 | lasso | 9 | 0.26 | 1.7e-06 | -6.63 | -6.9 | 6.0e-12 | 0.38 | 0.06 | 0.86 | FALSE |
29 | GTEx | Spleen | SHMT1 | 0.54 | 0.30 | lasso | 8 | 0.24 | 7.6e-07 | -6.43 | -6.4 | 1.5e-10 | 0.63 | 0.13 | 0.81 | FALSE |
30 | GTEx | Spleen | CTD-2303H24.2 | 0.32 | 0.02 | enet | 15 | 0.12 | 5.2e-04 | -6.64 | -5.9 | 3.2e-09 | 0.17 | 0.08 | 0.47 | FALSE |
31 | GTEx | Testis | CTD-2303H24.2 | 0.50 | 0.26 | lasso | 17 | 0.36 | 1.1e-16 | 5.37 | -5.7 | 1.1e-08 | 0.19 | 0.84 | 0.16 | FALSE |
32 | GTEx | Vagina | SHMT1 | 0.38 | 0.02 | lasso | 4 | -0.01 | 6.6e-01 | -6.64 | -7.0 | 2.5e-12 | 0.37 | 0.04 | 0.33 | FALSE |
33 | GTEx | Whole Blood | CTD-2303H24.2 | 0.04 | 0.02 | lasso | 4 | 0.04 | 8.4e-05 | -6.64 | -5.4 | 6.4e-08 | 0.18 | 0.07 | 0.81 | FALSE |
34 | ROSMAP | Brain Pre-frontal Cortex | LLGL1 | 0.23 | 0.07 | bslmm | 261 | 0.08 | 2.3e-10 | -7.06 | -5.4 | 5.2e-08 | 0.72 | 0.00 | 1.00 | FALSE |
35 | ROSMAP | Brain Pre-frontal Cortex | RP1-37N7.3 | 0.06 | 0.04 | lasso | 1 | 0.03 | 1.4e-04 | -6.09 | 6.1 | 1.1e-09 | -0.62 | 0.12 | 0.76 | FALSE |
36 | ROSMAP | Brain Pre-frontal Cortex | USP32P2 | 0.74 | 0.61 | enet | 18 | 0.65 | 4.4e-110 | 5.37 | -6.0 | 2.7e-09 | 0.20 | 0.98 | 0.02 | FALSE |
37 | YFS | Blood | LLGL1 | 0.21 | 0.12 | lasso | 9 | 0.14 | 1.9e-43 | -6.69 | 7.7 | 1.3e-14 | -0.81 | 0.02 | 0.98 | FALSE |
38 | YFS | Blood | TOP3A | 0.04 | 0.02 | enet | 20 | 0.03 | 9.3e-10 | -6.64 | -6.4 | 1.9e-10 | 0.21 | 0.01 | 0.99 | FALSE |
39 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | ALKBH5 | 0.05 | 0.02 | lasso | 2 | 0.03 | 3.1e-03 | 3.57 | 5.6 | 1.9e-08 | -0.31 | 0.03 | 0.56 | FALSE |
40 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FLII | 0.04 | 0.02 | blup | 48 | 0.03 | 2.2e-03 | -6.63 | 5.2 | 1.5e-07 | -0.18 | 0.02 | 0.62 | FALSE |
41 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | TOP3A | 0.05 | 0.01 | blup | 53 | 0.02 | 1.0e-02 | 4.28 | 5.2 | 2.0e-07 | -0.17 | 0.05 | 0.26 | FALSE |
42 | The Cancer Genome Atlas | Breast Invasive Carcinoma | ALKBH5 | 0.06 | 0.02 | blup | 63 | 0.02 | 7.2e-06 | -7.06 | 8.0 | 1.0e-15 | -0.77 | 0.00 | 0.98 | FALSE |
43 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FLII | 0.04 | 0.01 | blup | 47 | 0.02 | 7.2e-05 | -6.93 | 7.5 | 4.3e-14 | -0.48 | 0.02 | 0.82 | FALSE |
44 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LLGL1 | 0.09 | 0.01 | blup | 52 | 0.02 | 1.1e-05 | 1.57 | 5.6 | 2.6e-08 | -0.28 | 0.09 | 0.84 | FALSE |
45 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SMCR7 | 0.06 | 0.00 | enet | 7 | 0.02 | 1.5e-05 | -6.09 | 6.2 | 6.6e-10 | -0.37 | 0.01 | 0.70 | FALSE |
46 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SMCR8 | 0.02 | 0.01 | blup | 34 | 0.01 | 1.5e-02 | -6.09 | 6.3 | 2.3e-10 | -0.40 | 0.00 | 0.39 | FALSE |
47 | The Cancer Genome Atlas | Breast Invasive Carcinoma | TOP3A | 0.05 | 0.02 | enet | 8 | 0.03 | 1.2e-07 | 4.12 | 6.6 | 5.4e-11 | -0.37 | 0.04 | 0.96 | FALSE |
48 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | SMCR7 | 0.19 | 0.03 | blup | 33 | 0.06 | 4.5e-04 | -6.09 | 7.8 | 6.1e-15 | -0.62 | 0.01 | 0.83 | FALSE |
49 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | SMCR7 | 0.07 | 0.02 | lasso | 3 | 0.01 | 8.3e-03 | 2.46 | 5.7 | 1.0e-08 | -0.37 | 0.00 | 0.89 | FALSE |
50 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | SMCR8 | 0.10 | 0.02 | blup | 33 | 0.03 | 8.1e-05 | 1.17 | 5.7 | 9.6e-09 | -0.28 | 0.05 | 0.23 | FALSE |
51 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | TOP3A | 0.07 | 0.02 | blup | 48 | 0.02 | 1.3e-03 | -6.93 | 7.8 | 6.3e-15 | -0.46 | 0.00 | 0.97 | FALSE |
52 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SMCR7 | 0.04 | 0.01 | blup | 34 | 0.02 | 1.0e-03 | 4.25 | 5.4 | 7.3e-08 | -0.21 | 0.05 | 0.43 | FALSE |
53 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | FLII | 0.16 | 0.00 | enet | 6 | 0.06 | 1.4e-04 | -6.40 | 6.9 | 4.7e-12 | -0.42 | 0.02 | 0.32 | FALSE |
54 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | TOP3A | 0.11 | 0.01 | enet | 10 | 0.05 | 5.8e-04 | -6.93 | 8.1 | 5.2e-16 | -0.59 | 0.01 | 0.83 | FALSE |
55 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LLGL1 | 0.06 | 0.04 | enet | 2 | 0.04 | 3.6e-05 | -6.69 | -7.2 | 8.7e-13 | 0.95 | 0.00 | 0.98 | FALSE |
56 | The Cancer Genome Atlas | Brain Lower Grade Glioma | MYO15A | 0.04 | 0.02 | lasso | 3 | 0.02 | 2.5e-03 | -6.09 | 6.2 | 5.2e-10 | -0.36 | 0.06 | 0.26 | FALSE |
57 | The Cancer Genome Atlas | Lung Adenocarcinoma | ALKBH5 | 0.09 | 0.02 | lasso | 3 | 0.03 | 1.2e-04 | -6.93 | 8.3 | 7.3e-17 | -0.77 | 0.01 | 0.97 | FALSE |
58 | The Cancer Genome Atlas | Lung Adenocarcinoma | FLII | 0.04 | 0.01 | blup | 47 | 0.03 | 5.1e-04 | -6.93 | 6.5 | 6.6e-11 | -0.33 | 0.01 | 0.90 | FALSE |
59 | The Cancer Genome Atlas | Lung Adenocarcinoma | SMCR7 | 0.05 | 0.03 | enet | 7 | 0.05 | 3.7e-06 | -6.64 | 7.8 | 5.6e-15 | -0.49 | 0.00 | 0.99 | FALSE |
60 | The Cancer Genome Atlas | Lung Adenocarcinoma | SMCR8 | 0.06 | 0.01 | enet | 9 | 0.03 | 3.3e-04 | 4.12 | 5.7 | 1.4e-08 | -0.23 | 0.04 | 0.15 | FALSE |
61 | The Cancer Genome Atlas | Lung Adenocarcinoma | TOP3A | 0.08 | 0.04 | enet | 8 | 0.07 | 3.7e-08 | 4.28 | 7.3 | 3.4e-13 | -0.44 | 0.06 | 0.94 | FALSE |
62 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SMCR8 | 0.06 | 0.05 | lasso | 3 | 0.05 | 4.2e-04 | -6.12 | 6.7 | 2.9e-11 | -0.64 | 0.00 | 0.89 | FALSE |
63 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | TOP3A | 0.16 | 0.06 | lasso | 4 | 0.07 | 1.9e-05 | -6.12 | 6.9 | 5.6e-12 | -0.63 | 0.07 | 0.71 | FALSE |
64 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | ALKBH5 | 0.22 | 0.10 | blup | 66 | 0.12 | 1.4e-05 | -6.09 | 8.1 | 6.0e-16 | -0.73 | 0.04 | 0.79 | FALSE |
65 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | FLII | 0.20 | 0.08 | blup | 54 | 0.13 | 7.0e-06 | -1.30 | 5.8 | 5.7e-09 | -0.33 | 0.06 | 0.43 | FALSE |
66 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | SMCR7 | 0.13 | 0.05 | enet | 11 | 0.08 | 4.3e-04 | 4.03 | 6.3 | 3.5e-10 | -0.32 | 0.03 | 0.61 | FALSE |
67 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | TOP3A | 0.13 | 0.00 | enet | 12 | 0.06 | 2.3e-03 | 4.03 | 6.3 | 2.6e-10 | -0.45 | 0.03 | 0.10 | FALSE |
68 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ALKBH5 | 0.19 | 0.02 | blup | 63 | 0.04 | 3.4e-05 | -6.63 | 8.3 | 6.8e-17 | -0.68 | 0.03 | 0.93 | TRUE |
69 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FLII | 0.08 | 0.02 | enet | 6 | 0.04 | 1.9e-05 | 4.17 | 6.0 | 2.0e-09 | -0.39 | 0.06 | 0.59 | FALSE |
70 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SMCR7 | 0.07 | 0.04 | blup | 33 | 0.03 | 3.0e-04 | -6.93 | 7.1 | 1.2e-12 | -0.38 | 0.00 | 0.98 | FALSE |
71 | The Cancer Genome Atlas | Prostate Adenocarcinoma | TOP3A | 0.15 | 0.06 | lasso | 3 | 0.09 | 2.9e-09 | -6.69 | 7.5 | 6.7e-14 | -0.73 | 0.01 | 0.98 | FALSE |
72 | The Cancer Genome Atlas | Soft Tissue Sarcoma | TOP3A | 0.08 | 0.03 | enet | 24 | 0.04 | 1.6e-03 | 4.12 | 6.2 | 5.0e-10 | -0.38 | 0.03 | 0.74 | FALSE |
73 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FLII | 0.05 | 0.04 | blup | 47 | 0.03 | 1.7e-03 | -6.93 | 6.7 | 1.7e-11 | -0.37 | 0.01 | 0.83 | FALSE |
74 | The Cancer Genome Atlas | Stomach Adenocarcinoma | SMCR7 | 0.06 | 0.02 | enet | 7 | 0.04 | 9.1e-04 | 1.73 | 5.7 | 1.1e-08 | -0.41 | 0.01 | 0.72 | FALSE |
75 | The Cancer Genome Atlas | Stomach Adenocarcinoma | TOP3A | 0.09 | 0.06 | blup | 48 | 0.05 | 1.8e-04 | 4.17 | 6.5 | 7.4e-11 | -0.36 | 0.30 | 0.45 | FALSE |
76 | The Cancer Genome Atlas | Thyroid Carcinoma | SMCR7 | 0.10 | 0.01 | blup | 33 | 0.05 | 8.9e-06 | -6.09 | 6.8 | 1.3e-11 | -0.64 | 0.05 | 0.90 | TRUE |
77 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | SMCR8 | 0.60 | 0.03 | blup | 43 | 0.02 | 9.3e-02 | -6.40 | 6.0 | 2.2e-09 | -0.34 | 0.00 | 0.47 | FALSE |